KEGG   Acinonyx jubatus (cheetah): 106983958
Entry
106983958         CDS       T04657                                 
Name
(RefSeq) tumor necrosis factor
  KO
K03156  tumor necrosis factor superfamily, member 2
Organism
aju  Acinonyx jubatus (cheetah)
Pathway
aju01523  Antifolate resistance
aju04010  MAPK signaling pathway
aju04060  Cytokine-cytokine receptor interaction
aju04061  Viral protein interaction with cytokine and cytokine receptor
aju04064  NF-kappa B signaling pathway
aju04071  Sphingolipid signaling pathway
aju04150  mTOR signaling pathway
aju04210  Apoptosis
aju04217  Necroptosis
aju04350  TGF-beta signaling pathway
aju04380  Osteoclast differentiation
aju04612  Antigen processing and presentation
aju04620  Toll-like receptor signaling pathway
aju04621  NOD-like receptor signaling pathway
aju04622  RIG-I-like receptor signaling pathway
aju04625  C-type lectin receptor signaling pathway
aju04640  Hematopoietic cell lineage
aju04650  Natural killer cell mediated cytotoxicity
aju04657  IL-17 signaling pathway
aju04660  T cell receptor signaling pathway
aju04664  Fc epsilon RI signaling pathway
aju04668  TNF signaling pathway
aju04920  Adipocytokine signaling pathway
aju04930  Type II diabetes mellitus
aju04931  Insulin resistance
aju04932  Non-alcoholic fatty liver disease
aju04933  AGE-RAGE signaling pathway in diabetic complications
aju04936  Alcoholic liver disease
aju04940  Type I diabetes mellitus
aju05010  Alzheimer disease
aju05014  Amyotrophic lateral sclerosis
aju05020  Prion disease
aju05022  Pathways of neurodegeneration - multiple diseases
aju05132  Salmonella infection
aju05133  Pertussis
aju05134  Legionellosis
aju05135  Yersinia infection
aju05140  Leishmaniasis
aju05142  Chagas disease
aju05143  African trypanosomiasis
aju05144  Malaria
aju05145  Toxoplasmosis
aju05146  Amoebiasis
aju05152  Tuberculosis
aju05160  Hepatitis C
aju05161  Hepatitis B
aju05163  Human cytomegalovirus infection
aju05164  Influenza A
aju05165  Human papillomavirus infection
aju05166  Human T-cell leukemia virus 1 infection
aju05168  Herpes simplex virus 1 infection
aju05169  Epstein-Barr virus infection
aju05170  Human immunodeficiency virus 1 infection
aju05171  Coronavirus disease - COVID-19
aju05205  Proteoglycans in cancer
aju05310  Asthma
aju05321  Inflammatory bowel disease
aju05322  Systemic lupus erythematosus
aju05323  Rheumatoid arthritis
aju05330  Allograft rejection
aju05332  Graft-versus-host disease
aju05410  Hypertrophic cardiomyopathy
aju05414  Dilated cardiomyopathy
aju05417  Lipid and atherosclerosis
aju05418  Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:aju00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    106983958
   04350 TGF-beta signaling pathway
    106983958
   04064 NF-kappa B signaling pathway
    106983958
   04668 TNF signaling pathway
    106983958
   04071 Sphingolipid signaling pathway
    106983958
   04150 mTOR signaling pathway
    106983958
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    106983958
   04061 Viral protein interaction with cytokine and cytokine receptor
    106983958
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    106983958
   04217 Necroptosis
    106983958
 09150 Organismal Systems
  09151 Immune system
   04640 Hematopoietic cell lineage
    106983958
   04620 Toll-like receptor signaling pathway
    106983958
   04621 NOD-like receptor signaling pathway
    106983958
   04622 RIG-I-like receptor signaling pathway
    106983958
   04625 C-type lectin receptor signaling pathway
    106983958
   04650 Natural killer cell mediated cytotoxicity
    106983958
   04612 Antigen processing and presentation
    106983958
   04660 T cell receptor signaling pathway
    106983958
   04657 IL-17 signaling pathway
    106983958
   04664 Fc epsilon RI signaling pathway
    106983958
  09152 Endocrine system
   04920 Adipocytokine signaling pathway
    106983958
  09158 Development and regeneration
   04380 Osteoclast differentiation
    106983958
 09160 Human Diseases
  09161 Cancer: overview
   05205 Proteoglycans in cancer
    106983958
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    106983958
   05170 Human immunodeficiency virus 1 infection
    106983958
   05161 Hepatitis B
    106983958
   05160 Hepatitis C
    106983958
   05171 Coronavirus disease - COVID-19
    106983958
   05164 Influenza A
    106983958
   05168 Herpes simplex virus 1 infection
    106983958
   05163 Human cytomegalovirus infection
    106983958
   05169 Epstein-Barr virus infection
    106983958
   05165 Human papillomavirus infection
    106983958
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    106983958
   05135 Yersinia infection
    106983958
   05133 Pertussis
    106983958
   05134 Legionellosis
    106983958
   05152 Tuberculosis
    106983958
  09174 Infectious disease: parasitic
   05146 Amoebiasis
    106983958
   05144 Malaria
    106983958
   05145 Toxoplasmosis
    106983958
   05140 Leishmaniasis
    106983958
   05142 Chagas disease
    106983958
   05143 African trypanosomiasis
    106983958
  09163 Immune disease
   05310 Asthma
    106983958
   05322 Systemic lupus erythematosus
    106983958
   05323 Rheumatoid arthritis
    106983958
   05321 Inflammatory bowel disease
    106983958
   05330 Allograft rejection
    106983958
   05332 Graft-versus-host disease
    106983958
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    106983958
   05014 Amyotrophic lateral sclerosis
    106983958
   05020 Prion disease
    106983958
   05022 Pathways of neurodegeneration - multiple diseases
    106983958
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    106983958
   05418 Fluid shear stress and atherosclerosis
    106983958
   05410 Hypertrophic cardiomyopathy
    106983958
   05414 Dilated cardiomyopathy
    106983958
  09167 Endocrine and metabolic disease
   04930 Type II diabetes mellitus
    106983958
   04940 Type I diabetes mellitus
    106983958
   04936 Alcoholic liver disease
    106983958
   04932 Non-alcoholic fatty liver disease
    106983958
   04931 Insulin resistance
    106983958
   04933 AGE-RAGE signaling pathway in diabetic complications
    106983958
  09176 Drug resistance: antineoplastic
   01523 Antifolate resistance
    106983958
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04052 Cytokines and neuropeptides [BR:aju04052]
    106983958
   00536 Glycosaminoglycan binding proteins [BR:aju00536]
    106983958
Cytokines and neuropeptides [BR:aju04052]
 Cytokines
  Tumor necrosis fators
   106983958
Glycosaminoglycan binding proteins [BR:aju00536]
 Heparan sulfate / Heparin
  Cytokines
   106983958
SSDB
Motif
Pfam: TNF
Other DBs
NCBI-GeneID: 106983958
NCBI-ProteinID: XP_014937632
UniProt: A0A6J0A5Z6
LinkDB
Position
B2:complement(119616586..119619506)
AA seq 233 aa
MSTESMIRDVELAEEALPKKAGGPQGSRRCLCLSLFSFLLVAGATTLFCLLHFGVIGPQR
EELPHGLQLINPLPQTLRSSSRTPSDKPVAHVVANPEAEGQLQWLSRRANALLANGVELT
DNQLKVPSDGLYLIYSQVLFRGQGCPSTHVLLTHTISRFAVSYQTKVNLLSAIKSPCQRE
TPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINLPDYLDFAESGQVYFGIIAL
NT seq 702 nt   +upstreamnt  +downstreamnt
atgagcactgaaagcatgatccgggacgtggagctggccgaggaggcactccccaagaag
gcagggggcccccagggctccagaaggtgcttgtgcctcagcctcttctccttcctcctc
gtcgcaggagccaccacactcttctgcctgctgcactttggagtgatcggcccccagagg
gaagagctcccacatggcctgcaactaatcaaccctctgccccagacactcagatcatct
tctcgaactccgagtgacaagccagtagcccatgtagtagcaaaccccgaagctgaaggg
caactccagtggctgagccggcgtgccaatgccctcctggccaatggcgtggagctgaca
gacaaccagctgaaggtgccctcagatgggctgtacctcatctactcccaggtcctcttc
aggggccaaggatgtccttccacacatgtgctcctcacccacaccatcagccgctttgcc
gtttcctaccagaccaaggtcaacctcctctctgccatcaagagcccttgccagagggag
actccagagggggctgaggccaagccctggtatgagcccatctacctgggaggggtcttc
caactggagaagggtgatcgactcagcgctgagatcaatctgcctgactatcttgacttt
gccgagtctgggcaagtctactttggaatcattgccctgtga

DBGET integrated database retrieval system